E11.21
BillableType 2 diabetes mellitus with diabetic nephropathy
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is E11.21 an HCC code?
Yes. E11.21 maps to Diabetes with Chronic Complications under the CMS-HCC V28 risk adjustment model (and Diabetes with Chronic Complications under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for E11.21
For E11.21 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed E11.21 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
E11.21 is the ICD-10-CM diagnosis code for type 2 diabetes mellitus with diabetic nephropathy. Type 2 diabetes that has damaged the kidneys, causing diabetic nephropathy, which is kidney disease caused by high blood sugar levels. E11.21 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering diabetes mellitus (e08-e13).
Under the CMS-HCC V28 risk adjustment model, E11.21 maps to Diabetes with Chronic Complications (HCC 37) with a community, non-dual, aged base RAF weight of 0.245. Under the older V24 model, E11.21 mapped to the same category but with a base RAF weight of 0.302 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Nephropathy indicates kidney damage; ensure the documentation specifies diabetic nephropathy rather than other kidney conditions. Because E11.21 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for E11.21 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Nephropathy indicates kidney damage; ensure the documentation specifies diabetic nephropathy rather than other kidney conditions
- •This code does not specify the stage of chronic kidney disease; use additional codes if CKD stage is documented
Clinical Significance
Type 2 diabetes mellitus with diabetic nephropathy indicates kidney damage directly caused by chronic hyperglycemia, representing one of the most consequential microvascular complications of diabetes. Diabetic nephropathy is the leading cause of end-stage renal disease in the United States. Early stages are characterized by microalbuminuria progressing to overt proteinuria and declining glomerular filtration rate, ultimately requiring dialysis or kidney transplantation if not adequately managed.
Documentation Requirements
- ✓Documentation must establish a causal link between Type 2 diabetes and the nephropathy.
- ✓Laboratory values including urinary albumin-to-creatinine ratio, serum creatinine, and estimated glomerular filtration rate should be recorded.
- ✓If chronic kidney disease staging is documented (stages 1-5), an additional N18 code should be assigned.
- ✓Treatment with renin-angiotensin system inhibitors and glycemic optimization should be noted.